vs

Side-by-side financial comparison of CuriosityStream Inc. (CURI) and DNA X, Inc. (SONM). Click either name above to swap in a different company.

CuriosityStream Inc. is the larger business by last-quarter revenue ($19.2M vs $16.2M, roughly 1.2× DNA X, Inc.). CuriosityStream Inc. runs the higher net margin — -19.7% vs -29.3%, a 9.6% gap on every dollar of revenue. On growth, CuriosityStream Inc. posted the faster year-over-year revenue change (35.8% vs 7.9%). Over the past eight quarters, CuriosityStream Inc.'s revenue compounded faster (26.5% CAGR vs 9.9%).

Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.

CURI vs SONM — Head-to-Head

Bigger by revenue
CURI
CURI
1.2× larger
CURI
$19.2M
$16.2M
SONM
Growing faster (revenue YoY)
CURI
CURI
+27.9% gap
CURI
35.8%
7.9%
SONM
Higher net margin
CURI
CURI
9.6% more per $
CURI
-19.7%
-29.3%
SONM
Faster 2-yr revenue CAGR
CURI
CURI
Annualised
CURI
26.5%
9.9%
SONM

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CURI
CURI
SONM
SONM
Revenue
$19.2M
$16.2M
Net Profit
$-3.8M
$-4.8M
Gross Margin
11.2%
Operating Margin
-17.6%
-24.5%
Net Margin
-19.7%
-29.3%
Revenue YoY
35.8%
7.9%
Net Profit YoY
-34.6%
-89.2%
EPS (diluted)
$-0.07
$-4.83

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CURI
CURI
SONM
SONM
Q4 25
$19.2M
Q3 25
$18.4M
$16.2M
Q2 25
$19.0M
$11.2M
Q1 25
$15.1M
$16.7M
Q4 24
$14.1M
$15.3M
Q3 24
$12.6M
$15.0M
Q2 24
$12.4M
$11.5M
Q1 24
$12.0M
$9.1M
Net Profit
CURI
CURI
SONM
SONM
Q4 25
$-3.8M
Q3 25
$-3.7M
$-4.8M
Q2 25
$784.0K
$-7.5M
Q1 25
$319.0K
$458.0K
Q4 24
$-2.8M
$-21.6M
Q3 24
$-3.1M
$-2.5M
Q2 24
$-2.0M
$-6.6M
Q1 24
$-5.0M
$-2.9M
Gross Margin
CURI
CURI
SONM
SONM
Q4 25
Q3 25
11.2%
Q2 25
7.6%
Q1 25
50.0%
Q4 24
-1.2%
Q3 24
28.2%
Q2 24
25.8%
Q1 24
31.8%
Operating Margin
CURI
CURI
SONM
SONM
Q4 25
-17.6%
Q3 25
-24.5%
-24.5%
Q2 25
2.5%
-60.2%
Q1 25
0.5%
3.9%
Q4 24
-27.4%
55.3%
Q3 24
-25.8%
-15.8%
Q2 24
-20.6%
-56.2%
Q1 24
-30.4%
-29.5%
Net Margin
CURI
CURI
SONM
SONM
Q4 25
-19.7%
Q3 25
-20.4%
-29.3%
Q2 25
4.1%
-66.8%
Q1 25
2.1%
2.7%
Q4 24
-19.9%
-141.6%
Q3 24
-24.3%
-16.7%
Q2 24
-16.4%
-57.5%
Q1 24
-42.0%
-31.9%
EPS (diluted)
CURI
CURI
SONM
SONM
Q4 25
$-0.07
Q3 25
$-0.06
$-4.83
Q2 25
$0.01
$-0.79
Q1 25
$0.01
$0.08
Q4 24
$-0.05
$-116.99
Q3 24
$-0.06
$-9.32
Q2 24
$-0.04
$-1.41
Q1 24
$-0.09
$-0.65

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CURI
CURI
SONM
SONM
Cash + ST InvestmentsLiquidity on hand
$27.3M
$2.1M
Total DebtLower is stronger
$5.1M
Stockholders' EquityBook value
$41.5M
$-701.0K
Total Assets
$75.7M
$40.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CURI
CURI
SONM
SONM
Q4 25
$27.3M
Q3 25
$27.8M
$2.1M
Q2 25
$28.1M
$2.0M
Q1 25
$33.4M
$2.1M
Q4 24
$32.1M
$5.3M
Q3 24
$33.2M
$9.1M
Q2 24
$39.5M
$9.6M
Q1 24
$38.8M
$9.3M
Total Debt
CURI
CURI
SONM
SONM
Q4 25
Q3 25
$5.1M
Q2 25
$2.9M
Q1 25
$2.8M
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CURI
CURI
SONM
SONM
Q4 25
$41.5M
Q3 25
$47.2M
$-701.0K
Q2 25
$49.8M
$-1.3M
Q1 25
$58.1M
$-1.1M
Q4 24
$57.8M
$-5.7M
Q3 24
$62.2M
$15.3M
Q2 24
$64.8M
$17.5M
Q1 24
$67.0M
$19.8M
Total Assets
CURI
CURI
SONM
SONM
Q4 25
$75.7M
Q3 25
$74.7M
$40.2M
Q2 25
$78.7M
$36.1M
Q1 25
$85.3M
$36.0M
Q4 24
$86.2M
$39.7M
Q3 24
$87.6M
$49.1M
Q2 24
$90.9M
$45.9M
Q1 24
$94.6M
$42.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CURI
CURI
SONM
SONM
Operating Cash FlowLast quarter
$4.0M
$-7.0M
Free Cash FlowOCF − Capex
$3.9M
FCF MarginFCF / Revenue
20.5%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CURI
CURI
SONM
SONM
Q4 25
$4.0M
Q3 25
$4.4M
$-7.0M
Q2 25
$2.8M
$-4.9M
Q1 25
$1.9M
$-9.6M
Q4 24
$3.0M
$-4.5M
Q3 24
$2.3M
$-417.0K
Q2 24
$2.2M
$-3.4M
Q1 24
$666.0K
$-168.0K
Free Cash Flow
CURI
CURI
SONM
SONM
Q4 25
$3.9M
Q3 25
Q2 25
Q1 25
$1.8M
Q4 24
$-4.5M
Q3 24
$-554.0K
Q2 24
$-3.4M
Q1 24
$-198.0K
FCF Margin
CURI
CURI
SONM
SONM
Q4 25
20.5%
Q3 25
Q2 25
Q1 25
12.2%
Q4 24
-29.6%
Q3 24
-3.7%
Q2 24
-29.8%
Q1 24
-2.2%
Capex Intensity
CURI
CURI
SONM
SONM
Q4 25
0.1%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.5%
Q4 24
0.0%
0.1%
Q3 24
0.0%
0.9%
Q2 24
0.0%
0.3%
Q1 24
0.0%
0.3%
Cash Conversion
CURI
CURI
SONM
SONM
Q4 25
Q3 25
Q2 25
3.56×
Q1 25
6.03×
-20.97×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons